%20-%20Tint%20100.png?width=110&height=58&name=Logo%20-%20Standard%20-%20Blue%20(1080%20x%20597)%20-%20Tint%20100.png){kind=logo}
Translational Development
Amplitude Vascular Systems
Matthew Boyd and Brian Johnson are joined by Dr. Robert Chisena and Sean Gilligan from Amplitude Vascular Systems
×
Please feel out the form below and someone from our team will contact you shortly.
Duration: 60:03 Recorded September 2024
Guests
- Robert Chisena, PhD Co-Founder & CTO, AVS
- Sean Gilligan Chief Operations Officer, AVS
Transcript
On Point video shorts from the episode
The Choice
Why a physician would choose to use AVS' Pulse IVL™ therapy
The Market Impact
The impact of the Shockwave Medical acquisition on AVS
Technology Differentiation
Point of differentiation of AVS' Pulse IVL™ therapy
Commercial Discipline
Balancing urgency and discipline when commercializing a medical device
Mechanism of Action
The mechanism of action behind AVS' Pulse IVL™ technology
Enabling Technologies
The enabling technologies for intravascular lithotripsy
From Lab to VC
From university lab to venture funded start-up
Innovation Ecosystem
The benefits of proximity for biomedical engineering programs to healthcare systems
Technology Adoption
Rapid adoption of new technology in the healthcare industry
The School of Adversity
The benefits of adversity to entrepreneurs and start-ups
Rapid Fire
Rapid fire questions from Brian Johnson
Part of the Study
Translational Development
Why promising research stalls on the way to patients and how researchers become entrepreneurs by protecting IP, proving commercial viability, raising funds and building the right team
Additional Reading
.webp?width=1921&height=1081&name=Content%20Card%20-%20Just%20Mighty%20-%20Boyd%20-%20Two%20Color%20-%20Full%20(1920%20x%201080).webp)
.png?width=401&height=401&name=Logo%20-%20Just%20Mighty%20-%20White%20Logo%20(400%20x%20400).png){kind=logo}